Butterfly Network
BFLY · NYSE · Healthcare
$9.20
$0.68 (-7.35%) today
Market Cap
$2.45B
24h Volume
$71.6M
P/E Ratio
0.0
52w High
$9.93
52w Low
$1.90
Est. AI Revenue
60%
7-Day Sparkline (Static)
Company facts
Performance
About Butterfly Network
Butterfly Network makes handheld ultrasound devices built on semiconductor technology instead of traditional piezoelectric crystals. It makes money selling its probes and software subscriptions to clinicians who scan patients at the point of care.
AI is what makes the device usable beyond specialists: the Butterfly iQ3 probe pairs with AI-guided scanning that shows users how to capture the right image, automated image interpretation reads what the scan shows, and cloud AI diagnostics extend analysis beyond the device.
Founded in 2011 and headquartered in Burlington, Massachusetts, Butterfly trades on the NYSE and employs about 220 people.
Butterfly Network in the AI buildout
Butterfly sits in the AI Healthcare layer of the buildout as a device maker whose product depends on AI. Deep learning for guided scanning and automated interpretation is the core differentiator that lets non-specialists use ultrasound, so the thesis hinges on AI-enabled point-of-care imaging displacing traditional cart systems. That makes AI structural to the product rather than a feature, which earns it an AI Exposure Score of 55 out of 100.
BFLY is tracked in AI Healthcare, rated Strategic on the AI Exposure leaderboard.
By the numbers
52-week range
BFLY trades at $9.20, 91% of the way up its 52-week range of $1.90 to $9.93.
Market cap
Market capitalization is $2.45B, with an AI Exposure Score of 55 out of 100.
Next earnings
Butterfly Network is next expected to report earnings on October 30, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Butterfly Network do?
Butterfly makes handheld ultrasound probes built on semiconductor technology. Clinicians buy its devices and software subscriptions to scan patients at the point of care instead of relying on cart-based systems.
How is Butterfly Network exposed to AI?
AI is its core differentiator: guided scanning and automated interpretation let non-specialists capture and read ultrasound images. The thesis hinges on AI-enabled imaging displacing cart systems. Supercycle scores its exposure at 55 out of 100.
What are Butterfly's main products?
The Butterfly iQ3 AI ultrasound probe, automated image interpretation, AI-guided scanning that helps users capture the right image, and cloud AI diagnostics for analysis beyond the device.
Where is Butterfly headquartered and who leads it?
Butterfly is headquartered in Burlington, Massachusetts, and led by CEO Joe DeVivo. The company was founded in 2011, employs about 220 people, and its shares trade on the NYSE.
Is BFLY a pure play AI stock?
Not fully. Butterfly sells medical hardware whose usability depends on AI, placing it between adopters and pure plays. Its AI Exposure Score of 55 out of 100 sits in the upper middle of the leaderboard.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.